EMT-induced immune evasion: connecting the dots from mechanisms to therapy
- 15 November 2023
- journal article
- review article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (8) , 4265-4287
Abstract
Epithelial–mesenchymal transition (EMT) is a dynamic program crucial for organismal development and tissue regeneration. Unfortunately, this program is often hijacked by epithelial tumors to facilitate metastasis. Beyond its role in cancer spread, EMT increases cancer cell survival by activating stem cell programs and bypassing apoptotic programs. Importantly, the capacity of EMT to enforce tumor progression by altering the tumor cell phenotype without triggering immune responses opens the intriguing possibility of a mechanistic link between EMT-driven cancers and immune evasion. Indeed, EMT has been acknowledged as a of driver immune evasion, but the mechanisms are still evolving. Here, we review recent insights into the influence of EMT on tumor immune evasion. Specifically, we focus on the mechanistic roles of EMT in immune escape as the basis that may provide a platform for innovative therapeutic approaches in advanced tumors. We summarize promising therapeutic approaches currently in clinical trials and trending preclinical studies aimed at reinvigorating the tumor microenvironment to create immune-permissive conditions that facilitates immune-mediated tumor clearance. We anticipate that this will assist researchers and pharmaceutical companies in understanding how EMT compromises the immune response, potentially paving the way for effective cancer therapies.Keywords
This publication has 148 references indexed in Scilit:
- Epithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D ReceptorThe Journal of Immunology, 2013
- The epithelial–mesenchymal transition under control: Global programs to regulate epithelial plasticitySeminars in Cancer Biology, 2012
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and MetastasisCell, 2012
- Complexities of TGF-β Targeted Cancer TherapyInternational Journal of Biological Sciences, 2012
- Current and emerging concepts in tumour metastasisThe Journal of Pathology, 2010
- The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine‐specific demethylase 1The EMBO Journal, 2010
- Antiestrogens Induce Transforming Growth Factor β–Mediated Immunosuppression in Breast CancerCancer Research, 2010
- Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung CarcinomaClinical Cancer Research, 2009
- Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer CellsCancer Cell, 2009
- Human NK Cell Education by Inhibitory Receptors for MHC Class IImmunity, 2006